Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease.

Excessive inflammation seems important in chronic obstructive pulmonary disease (COPD), particularly during exacerbations of the disease. Exhaled nitric oxide concentration ([NOexh]) is a sensitive marker of bronchial inflammation in asthma; it is unclear if this is also the case in COPD. This study: 1) quantifies [NOexh] in patients with COPD (during an exacerbation and while clinically stable); 2) investigates the response of [NOexh] to i.v. steroid therapy, and its potential relationship with other relevant physiological variables; and 3) assesses the relative contributions of the central and peripheral airways to [NOexh] by collecting exhaled air in two different bags connected in series. Seventeen COPD patients (forced expiratory volume in one second (FEV1) 37.6+/-3.4% of the predicted value (+/-SEM)) hospitalized because of an exacerbation of the disease (arterial oxygen tension (Pa,O2) (7.46+/-0.72 kPa 56.1+/-5.4 mmHg), arterial carbon dioxide tension (Pa,CO2) 5.63+/-0.37 kPa 42.3+/-2.8 mmHg), pH 7.41+/-0.02) and 10 healthy subjects that served as controls were studied. On admission, [NOexh] in COPD was higher than normal (41.0+/-5.1 versus 13.3+/-0.8 parts per billion (ppb), respectively, p<0.001). Despite i.v. steroid therapy, [NOexh] remained elevated throughout recovery (37.9+/-4.8 ppb, p<0.001) until discharge (40.9+/-4.3 ppb, p<0.001). In contrast, when the patients were clinically stable (several months later), [NOexh] was significantly reduced (15.8+/-3.8 ppb, p<0.001), and no longer different from control values. [NOexh] was not related to any of the physiological variables measured during recovery (pulmonary gas exchange) or at discharge (forced spirometry, lung volumes, diffusing capacity). Finally, the contribution of the central and peripheral airways to [NOexh] was not different at any point in time. These results indicate that during exacerbations of chronic obstructive pulmonary disease, the exhaled nitric oxide concentration: 1) is higher than normal; 2) is not reduced acutely by i.v. steroids but is normalized several months after discharge; 3) is unrelated to several physiological indices of disease severity; and 4) appears to be produced homogeneously in central and peripheral airways. Overall, these results are different from those reported in asthma, suggesting that different inflammatory mechanisms are operating in both diseases.

[1]  P. Casán,et al.  Prediction equations for plethysmographic lung volumes. , 1998, Respiratory medicine.

[2]  W. Maziak,et al.  Exhaled nitric oxide in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[3]  P. Barnes,et al.  Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. , 1997, The European respiratory journal.

[4]  C. Piantadosi,et al.  Regulation of nitric oxide synthesis by oxygen in vascular endothelial cells. , 1997, The American journal of physiology.

[5]  W. MacNee,et al.  Prognostic significance of plasma D-dimer levels in patients with lung cancer. , 1997, Thorax.

[6]  P. Jeffery,et al.  Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. , 1997, American journal of respiratory and critical care medicine.

[7]  P. Barnes,et al.  Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. , 1997, American journal of respiratory and critical care medicine.

[8]  S. Kharitonov,et al.  Exhaled and nasal nitric oxide measurements : recommendations , 1997 .

[9]  D. Yates,et al.  Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. , 1996, American journal of respiratory and critical care medicine.

[10]  J. Dall'ava-Santucci,et al.  Exhaled nitric oxide during acute changes of airways calibre in asthma. , 1996, The European respiratory journal.

[11]  S. V. Von Essen,et al.  Measurement of exhaled nitric oxide by three different techniques. , 1996, American journal of respiratory and critical care medicine.

[12]  L. Wu,et al.  Oxygen upregulates nitric oxide synthase gene expression in ovine fetal pulmonary artery endothelial cells. , 1996, The American journal of physiology.

[13]  P. Barnes,et al.  Exhaled nitric oxide: a new lung function test. , 1996, Thorax.

[14]  D. Yates,et al.  Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. , 1996, The European respiratory journal.

[15]  L. Fabbri,et al.  Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa. , 1996, American journal of respiratory and critical care medicine.

[16]  L. Fabbri,et al.  Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. , 1995, American journal of respiratory and critical care medicine.

[17]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[18]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[19]  J. Stamler,et al.  Expired nitric oxide levels during treatment of acute asthma. , 1995, American journal of respiratory and critical care medicine.

[20]  P. Barnes,et al.  Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. , 1995, American journal of respiratory and critical care medicine.

[21]  P. Shaul,et al.  Oxygen modulates nitric oxide production selectively in fetal pulmonary endothelial cells. , 1994, American journal of respiratory cell and molecular biology.

[22]  J. Polak,et al.  Expression of inducible nitric oxide in human lung epithelial cells. , 1994, Biochemical and biophysical research communications.

[23]  P. J. Barnes,et al.  Increased nitric oxide in exhaled air of asthmatic patients , 1994, The Lancet.

[24]  P. Howarth,et al.  Induction of nitric oxide synthase in asthma , 1993, The Lancet.

[25]  W. MacNee,et al.  Neutrophil retention in the lungs of patients with chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.

[26]  J. Roca,et al.  Single-breath carbon monoxide diffusing capacity prediction equations from a Mediterranean population. , 1990, The American review of respiratory disease.

[27]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[28]  A. Buist.  Standardization of spirometry. , 1987, The American review of respiratory disease.

[29]  D. Navajas,et al.  Spirometric reference values from a Mediterranean population. , 1986, Bulletin europeen de physiopathologie respiratoire.

[30]  J. Clausen,et al.  Pulmonary function testing guidelines and controversies : equipment, methods, and normal values , 1982 .